Physician profile
David M Lintner
NPI 1316982929
$22,467.57
in general payments reported to CMS, 2019-2025
9 companies · $400 in 2025
The $400 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $2,411 · 2021: $2,297 · 2022: $168 · 2023: $306 · 2024: $1,233 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,135 · Travel and Lodging: $804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,135.02 |
| Travel and Lodging | $803.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $11,839.27 | 2019 | |
| Medinc of Texas | $5,383.72 | 2019-2023 | |
| Smith+Nephew, INC. | $3,387.93 | 2020-2025 | Bone Anchors With Arthroscopic Delivery System, Healicoil, Footprint |
| Vericel Corporation | $1,209.34 | 2019-2024 | Maci |
| Arthrex, INC. | $514.27 | 2020-2024 | Shoulder Implants Elbow Ucl |
| Vertex Pharmaceuticals Incorporated | $41.33 | 2025 | |
| Bioventus LLC | $39.78 | 2025 | Gelsyn-3 |
| Depuy Synthes Sales INC. | $31.23 | 2021-2025 | Orthovisc, Monovisc |
| Alafair Biosciences, INC. | $20.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lintner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.